Indian Journal of Urology: Table of Contents

Users online:399

Home

Current Issue

Ahead of print

Editorial Board

Archives

Symposia

Guidelines

Subscriptions

Article Cited by others

Randomized double-blind controlled clinical trial of serenoa repens versus placebo in the management of patients with symptomatic grade I to grade II benign prostatic hyperplasia (BPH).

Mohanty N K, Jha R J, Dutt C

Year : 1999| Volume: 15| Issue : 1 | Page no: 26-31

This article has been cited by

1	Serenoa repens monotherapy for benign prostatic hyperplasia (BPH): An updated Cochrane systematic review

	MacDonald, R. and Tacklind, J.W. and Rutks, I. and Wilt, T.J.

	BJU International. 2012; 109(12): 1756-1761

	[Pubmed] [Google Scholar]

2	Evidence-based systematic review of Saw palmetto by the Natural Standard Research Collaboration

	Ulbricht, C. and Basch, E. and Bent, S. and Boon, H. and Corrado, M. and Foppa, I. and Hashmi, S. and Hammerness, P. and Kingsbury, E. and Smith, M. and Szapary, P. and Vora, M. and Weissner, W.

	Journal of the Society for Integrative Oncology. 2006; 4(4): 170-186

	[Pubmed] [Google Scholar]